297.50
-0.5(-0.17%)
Currency In TWD
Address
No. 277 Song Ren Road
Taipei, 110
Taiwan, Province of China
Phone
886 2 2700 5908
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Employees
1099
First IPO Date
December 21, 2007
| Name | Title | Pay | Year Born |
| Mr. Petar Antonov Vazharov | Chief Executive Officer | 34.72M | N/A |
| Ms. Eeling Chan | Chief Financial Officer | 5.19M | N/A |
| Mr. Bjartur Shen | Vice President of Strategies & Finance | 21.06M | N/A |
| Yingming Yue | Vice President | 0 | N/A |
| Valerie Lau | Chief Commercial Officer-APAC | 0 | N/A |
| Ms. Gwen Hsieh | Chief Information Officer | 0 | N/A |
| Boon Chong Tan | Deputy General Manager | 0 | N/A |
| Mr. Edin Buljubasic | Vice President | 0 | N/A |
| Mr. Vamsi Kiran Kosaraju | Chief Operations Officer | 0 | N/A |
| Ms. Yu-Ying Yang | Associate Director of Co-Operate Communication | 0 | N/A |
Lotus Pharmaceutical Co., Ltd. research, develops, manufactures, and sells generic pharmaceutical products in Taiwan, Korea, the United States, and internationally. Its product portfolio focuses on generics in the fields of oncology, cardiology, nephrology, women's health, anti-obesity, and central nervous system disease. The company also sells and markets a portfolio of over-the-counter medicines. In addition, it engages in wholesale of cosmetics; retail of clinical machines; biotech technological consulting services; sale of pharmaceuticals and medicinal chemical; marketing activities; market planning and business information services; and consultancy services on health management, health technology, and trading information services. Further, the company offers pharmaceutical regulatory affairs project management, and data collection and agency services; healthcare consultancy services and operates as a contract research organization. Lotus Pharmaceutical Co., Ltd. was incorporated in 1966 and is headquartered in Taipei City, Taiwan. Lotus Pharmaceutical Co., Ltd. is a subsidiary of Alvogen Emerging Markets Holdings Limited.